K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
D000293:Adolescent; D000328:Adult; D002318:Cardiovascular Diseases / Q000150:complications*; D002423:Cause of Death; D002648:Child; D004032:Diet; D018450:Disease Progression; D015444:Exercise; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006949:Hyperlipidemias / Q000150:complications / Q000453:epidemiology / Q000628:therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000628:therapy; D016030:Kidney Transplantation; D015995:Prevalence; D006435:Renal Dialysis; D012307:Risk Factors
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents